Incorvaia, L., Fanale, D., Badalamenti, G., Brando, C., Bono, M., De Luca, I., . . . Bazan, V. (2020). A “Lymphocyte MicroRNA Signature” as Predictive Biomarker of Immunotherapy Response and Plasma PD-1/PD-L1 Expression Levels in Patients with Metastatic Renal Cell Carcinoma: Pointing towards Epigenetic Reprogramming. Cancers (Basel).
Chicago Style CitationIncorvaia, Lorena, et al. "A “Lymphocyte MicroRNA Signature” As Predictive Biomarker of Immunotherapy Response and Plasma PD-1/PD-L1 Expression Levels in Patients With Metastatic Renal Cell Carcinoma: Pointing Towards Epigenetic Reprogramming." Cancers (Basel) 2020.
Cita MLAIncorvaia, Lorena, et al. "A “Lymphocyte MicroRNA Signature” As Predictive Biomarker of Immunotherapy Response and Plasma PD-1/PD-L1 Expression Levels in Patients With Metastatic Renal Cell Carcinoma: Pointing Towards Epigenetic Reprogramming." Cancers (Basel) 2020.